Stat6 is necessary and sufficient for IL-4's role in Th2 differentiation and cell expansion

被引:216
|
作者
Zhu, JF [1 ]
Guo, LY [1 ]
Watson, CJ [1 ]
Hu-Li, J [1 ]
Paul, WE [1 ]
机构
[1] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA
来源
JOURNAL OF IMMUNOLOGY | 2001年 / 166卷 / 12期
关键词
D O I
10.4049/jimmunol.166.12.7276
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IL-4 plays a critical role in the differentiation of TCR-stimulated naive CD4 T cells to the Th2 phenotype. In response to IL-4, the IL-4R activates a set of phosphotyrosine binding domain-containing proteins, including insulin receptor substrate 1/2, Shc, and IL-4R interacting protein, as well as Stat6. Stat6 has been shown to be required for Th2 differentiation. To determine the roles of the phosphotyrosine binding adaptors in Th2 differentiation, we prepared a retrovirus containing a mutant of the human (h)IL-4R alpha -chain, Y497F, which is unable to recruit these adaptors. The mutant hIL-4R alpha, as well as the wild-type (WT) hIL-4R alpha, was introduced into naive CD4 T cells. Upon hIL-4 stimulation, Y497F worked as well as the WT hIL-4R alpha in driving Th2 differentiation, as measured by Gata3 up-regulation and IL-4 production. Furthermore, IL-4-driven cell expansion was also normal in the cells infected with Y497F, although cells infected with Y497F were not capable of phosphorylating insulin receptor substrate 2. These results suggest that the signal pathway mediated by Y497 is dispensable for both IL-4-driven Th2 differentiation and cell expansion. Both WT and Y497F hIL-4R alpha lose the ability to drive Th2 differentiation and cell expansion in Stat6-knockout CD4 T cells. A constitutively activated form of Stat6 introduced into CD4 T cells resulted in both Th2 differentiation and enhanced cell expansion. Thus, activated Stat6 is necessary and sufficient to mediate both IL-4-driven Th2 differentiation and cell expansion in CD4 T cells.
引用
收藏
页码:7276 / 7281
页数:6
相关论文
共 50 条
  • [21] Single cell analysis reveals that IL-4 receptor/Stat6 signaling is not required for the in vivo or in vitro development of CD4+ lymphocytes with a Th2 cytokine profile
    Jankovic, D
    Kullberg, MC
    Noben-Trauth, N
    Caspar, P
    Paul, WE
    Sher, A
    JOURNAL OF IMMUNOLOGY, 2000, 164 (06): : 3047 - 3055
  • [22] Interferon-[gamma] suppresses STAT6 phosphorylation in Th1 cells by inhibiting the recruitment of STAT6 to the IL-4 receptor
    Huang, H
    Huang, Z
    Xin, JP
    Coleman, J
    FASEB JOURNAL, 2004, 18 (04): : A57 - A57
  • [23] RETRACTED: Punicalagin Alleviates Aged Bronchial Asthma by Inhibiting Th2 Differentiation through IL-4/STAT6 and Jagged1/Notch Pathways (Retracted Article)
    Yu, Li
    Li, Jianying
    JOURNAL OF HEALTHCARE ENGINEERING, 2022, 2022
  • [24] Integration of TCR and IL-4 signals through STAT6 and the regulation of IL-4 gene expression
    Schmidt-Weber, CB
    Rao, A
    Lichtman, AH
    MOLECULAR IMMUNOLOGY, 2000, 37 (12-13) : 767 - 774
  • [25] Grail controls Th2 cell development by targeting STAT6 for degradation
    Anupama Sahoo
    Andrei Alekseev
    Lidiya Obertas
    Roza Nurieva
    Nature Communications, 5
  • [26] Grail controls Th2 cell development by targeting STAT6 for degradation
    Sahoo, Anupama
    Alekseev, Andrei
    Obertas, Lidiya
    Nurieva, Roza
    NATURE COMMUNICATIONS, 2014, 5
  • [27] Development and expansion of Ag-specific Th2 cell in the absence of IL-4 in vivo
    Liu, Z
    Liu, Q
    Hamed, H
    Foster, A
    VanNoy, J
    Urban, JF
    Gause, WC
    FASEB JOURNAL, 2004, 18 (04): : A422 - A422
  • [28] Il-18 stimulates TH2 differentiation in an Il-4 independent manner
    Wild, JS
    Choudhury, BK
    Alam, R
    Sur, S
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 107 (02) : S60 - S60
  • [29] Therapeutic effects of Pulsatilla koreana Nakai extract on ovalbumin-induced allergic rhinitis by inhibition of Th2 cell activation and differentiation via the IL-4/STAT6/GATA3 pathway
    Jung, Dong Ho
    Lee, Ami
    Hwang, Youn-Hwan
    Jung, Myung-A.
    Pyun, Bo-Jeong
    Lee, Joo Young
    Kim, Taesoo
    Song, Kwang Hoon
    Ji, Kon-Young
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 162
  • [30] STAT6 may not be required for TH2 commitment.
    Mullen, AC
    Reilly, NL
    Brown, DR
    Reiner, SL
    FASEB JOURNAL, 2000, 14 (06): : A988 - A988